ApexBio Revenue
Biotechnology Research • 
Tel Aviv, Tel-Aviv District, Israel • 1-10 Employees
$
ApexBio revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at ApexBio
Rom Zilberberg
Chief Executive Officer
Company overview
| Headquarters | Tel Aviv, Tel-Aviv District, Israel |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
About ApexBio
ApexBio is developing a ground-breaking therapies for neurodegenerative diseases, with a primary focus on Alzheimer’s disease.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
ApexBio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
ApexBio has never raised funding before.
United Kingdom
Italy
United States
Romania
Ukraine
Frequently asked questions
ApexBio is located in Tel Aviv, Tel-Aviv District, IL.
ApexBio generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
ApexBio has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
ApexBio was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
ApexBio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
